UPL Limited

Examples Of Forward

looking statements

30%

R&D crop protection centres 39 R&D seeds centres Leading specialty chemicals company in India >30% agchem portfolio is IP protected >16,000 product registrations >3,200 patents ~16% innovat

16%

India >30% agchem portfolio is IP protected >16,000 product registrations >3,200 patents ~16% innovation rate in agchem platform ~20% innovation index in seeds Manufacturing Innovation

20%

cted >16,000 product registrations >3,200 patents ~16% innovation rate in agchem platform ~20% innovation index in seeds Manufacturing Innovation (1) by DJSI: Dow Jones Sustainability Index

8%

erformance for the year, led by our resilient core, focus and discipline. . . Revenue Growth 4–8% Guidance for FY26 +11% Achieved EBITDA Growth 12–16% Upgraded Guidance for FY26 +18% Achie

11%

led by our resilient core, focus and discipline. . . Revenue Growth 4–8% Guidance for FY26 +11% Achieved EBITDA Growth 12–16% Upgraded Guidance for FY26 +18% Achieved Net Debt to EBITDA

18%

owth 4–8% Guidance for FY26 +11% Achieved EBITDA Growth 12–16% Upgraded Guidance for FY26 +18% Achieved Net Debt to EBITDA 1.6–1.8x Guidance for FY26 <1.6x Achieved Outperformed Full-year

1.8x

hieved EBITDA Growth 12–16% Upgraded Guidance for FY26 +18% Achieved Net Debt to EBITDA 1.6–1.8x Guidance for FY26 <1.6x Achieved Outperformed Full-year Guidance Across Metrics Volume led gro

1.6x

–16% Upgraded Guidance for FY26 +18% Achieved Net Debt to EBITDA 1.6–1.8x Guidance for FY26 <1.6x Achieved Outperformed Full-year Guidance Across Metrics Volume led growth across key markets B

40%

p.a. added to global farming area (e.g., Brazil) Key drivers for sustainable global agriculture ~40% of crop production lost to pests, diseases, weeds Climate change accelerates pest reproduction an

25%

-protection and Bio-solutions to grow substantially Post patent Proprietary off-patent Patented 25% 16% 2011 59% 10% 12% 2024 7% 11% 2029E 78% 82% Global Crop protection Global Bio-solut

59%

Bio-solutions to grow substantially Post patent Proprietary off-patent Patented 25% 16% 2011 59% 10% 12% 2024 7% 11% 2029E 78% 82% Global Crop protection Global Bio-solutions in $ bn i

10%

olutions to grow substantially Post patent Proprietary off-patent Patented 25% 16% 2011 59% 10% 12% 2024 7% 11% 2029E 78% 82% Global Crop protection Global Bio-solutions in $ bn in $ b

“quality products, value pricing and reliable suppliers Notes: Bio-solutions industry is a part of crop-protection industry; plant growth regulator is a part of bio-solutions industry Source: Internal estimates, S&P Global, AgbioInvestor 12 UPL in FY27 Accelerating Profitable Growth.”

“Bikash Prasad, Group Chief Financial Officer 15 FY26 A Year of Driving Profitable Growth .”

“18 UPL Limited FY26 | Performance Dashboard Summary UPL Delivers Strong Performance, Led by Operational Excellence and Continued Financial Discipline; Beats Guidance +11% ₹51,839 cr | V: +8% | P: (3%) | F: +6% +17% | +220bps ₹21,338 cr | 41.2% +18% | +110bps ₹9,588 cr | 18.5% Revenue Contribution & Margin EBITDA & Margin >2x ₹1,921 cr PATMI >2.5x ₹1,860 cr +4 days 57 days | ₹8,119 cr Operational PATMI(1) NWC Days Lower by $850 Mn $2,325 Mn Lower by ~$400 Mn $1,616 Mn <1.6x vs.”

“LY FY26 Contribution Analysis(1)(2) (₹ cr) FY25 FY26 YoY +17% +20% +19% +22% +13% 21,338 18,173 11,178 13,420 UPL Limited UPL Corp UPL SAS Advanta SUPERFORM CM % 39% 41% 33% 35% 27% 32% 57% 56% 22% 25% 866 1,033 3,164 3,850 2,265 2,549 UPL Corp • Driven by lower input cost and higher capacity utilization Advanta • Volume led growth, stable margins UPL SAS • Improvement led by improved product mix and new launches SUPERFORM • Improved margin from higher mix of SSC(3) segment vs.”

“LY, driven by higher EBITDA, lower finance cost and A.I./ JV losses FY26 Operational PATMI(1) Bridge (₹ cr) 1,463 513 66 31 278 (494) (336) (375) 714 FY25 EBITDA D&A NFC FX/ Hedging cost Oth.”

“NCI FY26 NFC • Debt repayment of ~$250 Mn in FX/ Hedging cost • Favorable mark-to-market Mar’25, lower finance cost (SOFR), rating outlook upgrade movement Associate income / JV • Improvement in most investments vs.”

“& FCTR Net Operating cash flow Income tax paid Capex Investments Free cash flow to firm (FCFF) Net interest paid Free cash flow to equity (FCFE)(2) FCFE adjusted for “changes in working capital” (seasonal)(2) FY24 3,609 (748) 76 2,937 (1,143) (1,955) (593) (754) (3,136) (3,890) (3,142) FY25 6,907 3,093 662 10,662 (983) (1,254) (871) 7,555 (3,027) 4,528 1,435 FY26 8,959 (1,224) 938 8,672 (571) (2,352) (156) 5,593 (2,367) 3,226 4,450 Change vs.”

“Cash and cash equivalent include current investment 31 Platform-wise Q4 and FY26 Performance Update 32 Accelerating Profitable Growth.”

“Mike Frank, Chief Executive Officer UPL Corp FY26 | Key Highlights Driving growth through commercial & operational excellence, accelerated by innovation .”

“Innovation rate is innovation sales rate compared to total annual sales.​ 40 UPL Corp | Summary On pathway for sustainable and profitable growth Strong FY26 Performance FY27 Strategy for Sustainable Growth ➢ Outpaced market in vol.”

Growers return to core priorities

1

Growers return to core priorities

quality products, value pricing and reliable suppliers Notes: Bio-solutions industry is a part of crop-protection industry; plant growth regulator is a part of bio-solutions industry Source: Internal estimates, S&P Global, AgbioInvestor 12 UPL in FY27 Accelerating Profitable Growth. 13 UPL Limited | Accelerating Profitable Growth Continue to build on current capabilities by leveraging technology, while evaluating new profitable business streams Crop Protection Seeds • Focus on differentiated/ • Product innovation sustainable portfolio, innovation rate • Deeper channel engagement • Germplasm expansion • Decco scale-up post integration Specialty Chemicals / Manufacturing • Scaling-up specialty chemicals • Manufacturing excellence: positioning for “China Plus One” and nearshoring • Continue to focus on backward integration Leveraging Internal Capabilities and Enablers • R&D and innovation • “Future-fit” organization • Accelerate global Centres of Excellence (e.g., India, Colombia, Mauriti